Zoetis Stock Price, News & Analysis (NYSE:ZTS)

$76.33 -0.44 (-0.57 %)
(As of 01/19/2018 03:41 PM ET)
Previous Close$76.77
Today's Range$75.85 - $76.65
52-Week Range$52.00 - $77.03
Volume2.59 million shs
Average Volume2.44 million shs
Market Capitalization$37.25 billion
P/E Ratio40.17
Dividend Yield0.56%
Beta1.06

About Zoetis (NYSE:ZTS)

Zoetis logoZoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers. Its livestock products include Ceftiofur injectable line, Draxxin, Spectramast, Bovi-Shield line, Rispoval line, Suvaxyn/Fostera, Embrex devices and Lutalyse. Its companion animal products include Clavamox/Synulox, Convenia, ProHeart, Revolution/Stronghold, Apoquel, Cerenia and Rimadyl.

Receive ZTS News and Ratings via Email

Sign-up to receive the latest news and ratings for ZTS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Veterinary Drugs
Sub-IndustryPharmaceuticals
SectorHealthcare
SymbolNYSE:ZTS
CUSIP98978V10
Phone+1-973-8227000

Debt

Debt-to-Equity Ratio2.45%
Current Ratio2.80%
Quick Ratio1.95%

Price-To-Earnings

Trailing P/E Ratio40.1736842105263
Forward P/E Ratio32.34
P/E Growth1.84

Sales & Book Value

Annual Sales$4.89 billion
Price / Sales7.61
Cash Flow$2.45 per share
Price / Cash31.20
Book Value$3.04 per share
Price / Book25.11

Profitability

Trailing EPS$1.90
Net Income$821 million
Net Margins18.29%
Return on Equity62.39%
Return on Assets13.29%

Miscellaneous

Employees9,000
Outstanding Shares487,290,000

Zoetis (NYSE:ZTS) Frequently Asked Questions

What is Zoetis' stock symbol?

Zoetis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZTS."

How often does Zoetis pay dividends? What is the dividend yield for Zoetis?

Zoetis announced a quarterly dividend on Tuesday, December 12th. Investors of record on Friday, January 19th will be given a dividend of $0.126 per share on Thursday, March 1st. This represents a $0.50 annualized dividend and a dividend yield of 0.66%. The ex-dividend date of this dividend is Thursday, January 18th. This is a boost from Zoetis's previous quarterly dividend of $0.11. View Zoetis' Dividend History.

How were Zoetis' earnings last quarter?

Zoetis Inc (NYSE:ZTS) announced its quarterly earnings results on Thursday, November, 2nd. The company reported $0.65 EPS for the quarter, topping analysts' consensus estimates of $0.63 by $0.02. The company earned $1.35 billion during the quarter, compared to analysts' expectations of $1.32 billion. Zoetis had a net margin of 18.29% and a return on equity of 62.39%. The firm's quarterly revenue was up 8.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.52 earnings per share. View Zoetis' Earnings History.

When will Zoetis make its next earnings announcement?

Zoetis is scheduled to release their next quarterly earnings announcement on Thursday, February, 15th 2018. View Earnings Estimates for Zoetis.

What guidance has Zoetis issued on next quarter's earnings?

Zoetis updated its FY17 earnings guidance on Thursday, November, 2nd. The company provided earnings per share (EPS) guidance of $2.34-$2.39 for the period, compared to the Thomson Reuters consensus estimate of $2.34. The company issued revenue guidance of $5.225-$5.275 billion, compared to the consensus revenue estimate of $5.20 billion.

Where is Zoetis' stock going? Where will Zoetis' stock price be in 2018?

17 equities research analysts have issued twelve-month target prices for Zoetis' shares. Their forecasts range from $35.00 to $89.00. On average, they expect Zoetis' share price to reach $73.18 in the next year. View Analyst Ratings for Zoetis.

What are Wall Street analysts saying about Zoetis stock?

Here are some recent quotes from research analysts about Zoetis stock:

  • 1. According to Zacks Investment Research, "Zoetis faces stiff competition from other animal health medicines and vaccines companies like Merck Animal Health (the animal health division of Merck), Elanco (the animal health division of Eli Lilly), Bayer Animal Health (the animal health division of Bayer) and Boehringer Ingelheim Animal Health (the animal health division of Boehringer Ingelheim). Disease outbreak among animals is a material cause of concern for Zoetis’ livestock products.In addition, companion animal health products are often directly prescribed and dispensed by veterinarians. The swine business is being impacted by competition for Fostera. These competitive pressures could adversely affect the company’s business and operating results. However, shares of the company have outperformed the industry in the last six months." (1/13/2018)
  • 2. Cantor Fitzgerald analysts commented, "IDEXX Laboratories this morning provided strong 2018 organic growth forecasts of 9% to 11% driven by the strong growth in its Companion Animal Diagnostics segment." (10/31/2017)
  • 3. Guggenheim analysts commented, "We are raising our PT for ZTS shares after a 4Q beat and a lower than expected FX headwind for '17. The increase in our PT is driven by multiple expansion. We arrive at our new PT by using a DCF analysis. ZTS's solid execution this quarter increases our confidence that it can exceed consensus expectations for '17+ and sustain its 21x forward P/E multiple. Upward earnings revisions could come from margin expansion, M&A, and launches. Therefore, the sell-off today, which we think is motivated by profit taking, is overdone, in our view. We believe the weakness (ZTS down 3% vs. S&P down 0.14%) presents a good buying opportunity for the stock." (2/16/2017)

Who are some of Zoetis' key competitors?

Who are Zoetis' key executives?

Zoetis' management team includes the folowing people:

  • Juan Ramon Alaix, Chief Executive Officer, Director (Age 65)
  • Glenn David, Chief Financial Officer, Executive Vice President (Age 46)
  • Roxanne Lagano, Chief Human Resource Officer, Executive Vice President (Age 52)
  • Andrew Fenton, Executive Vice President, Chief Information Officer (Age 52)
  • Heidi C. Chen, Executive Vice President, General Counsel, Corporate Secretary (Age 50)
  • Alejandro Bernal, Executive Vice President, Group President - Strategy, Commercial and Business Development (Age 44)
  • Catherine A. Knupp, Executive Vice President, President - Research and Development (Age 56)
  • Clinton A. Lewis Jr., Executive Vice President, President - International Operations (Age 51)
  • Kristin C. Peck, Executive Vice President, President - U.S. Operations (Age 46)
  • Roman Trawicki, Executive Vice President, President of Global Manufacturing and Supply (Age 53)

Who owns Zoetis stock?

Zoetis' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Frontier Capital Management Co. LLC (0.41%), Schwab Charles Investment Management Inc. (0.36%), Acadian Asset Management LLC (0.35%), AMI Asset Management Corp (0.12%), Milestone Resources Group Ltd (0.11%) and National Pension Service (0.09%). Company insiders that own Zoetis stock include Andrew Fenton, Catherine A Knupp, Heidi C Chen, Kristin C Peck, Michael B Mccallister, Pershing Square Capital Manage and Roxanne Lagano. View Institutional Ownership Trends for Zoetis.

Who sold Zoetis stock? Who is selling Zoetis stock?

Zoetis' stock was sold by a variety of institutional investors in the last quarter, including Pennsylvania Trust Co, Vontobel Asset Management Inc., Atalanta Sosnoff Capital LLC, Frontier Capital Management Co. LLC, Bank of Montreal Can, First Citizens Bank & Trust Co., AMI Asset Management Corp and Exxonmobil Investment Management Inc. TX. View Insider Buying and Selling for Zoetis.

Who bought Zoetis stock? Who is buying Zoetis stock?

Zoetis' stock was bought by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Milestone Resources Group Ltd, Schwab Charles Investment Management Inc., Copper Rock Capital Partners LLC, National Pension Service, Westpac Banking Corp, Chesley Taft & Associates LLC and Neville Rodie & Shaw Inc.. View Insider Buying and Selling for Zoetis.

How do I buy Zoetis stock?

Shares of Zoetis can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Zoetis' stock price today?

One share of Zoetis stock can currently be purchased for approximately $76.33.

How big of a company is Zoetis?

Zoetis has a market capitalization of $37.25 billion and generates $4.89 billion in revenue each year. The company earns $821 million in net income (profit) each year or $1.90 on an earnings per share basis. Zoetis employs 9,000 workers across the globe.

How can I contact Zoetis?

Zoetis' mailing address is 10 Sylvan Way, PARSIPPANY, NJ 07054-3825, United States. The company can be reached via phone at +1-973-8227000 or via email at [email protected]


MarketBeat Community Rating for Zoetis (ZTS)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  486 (Vote Outperform)
Underperform Votes:  281 (Vote Underperform)
Total Votes:  767
MarketBeat's community ratings are surveys of what our community members think about Zoetis and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Zoetis (NYSE:ZTS) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.712.692.632.67
Ratings Breakdown: 1 Sell Rating(s)
3 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
3 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $73.18$68.38$65.44$63.06
Price Target Upside: 4.68% downside4.73% downside3.33% upside0.49% upside

Zoetis (NYSE:ZTS) Consensus Price Target History

Price Target History for Zoetis (NYSE:ZTS)

Zoetis (NYSE:ZTS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/18/2018Piper Jaffray CompaniesReiterated RatingBuy$86.00LowView Rating Details
1/16/2018Jefferies GroupReiterated RatingBuy$89.00HighView Rating Details
1/11/2018Cantor FitzgeraldSet Price TargetBuy$85.00LowView Rating Details
1/9/2018BMO Capital MarketsBoost Price TargetPositive -> Market Perform$78.00MediumView Rating Details
1/4/2018CitigroupUpgradeNeutral -> Buy$85.00LowView Rating Details
1/2/2018Craig HallumReiterated RatingBuy$77.00 -> $85.00LowView Rating Details
11/29/2017Morgan StanleyUpgradeEqual Weight -> Overweight$80.00LowView Rating Details
11/17/2017CowenSet Price TargetBuy$70.00 -> $80.00N/AView Rating Details
10/24/2017Stifel NicolausReiterated RatingBuy$65.00N/AView Rating Details
8/7/2017Goldman Sachs GroupReiterated RatingNeutral -> Neutral$62.00LowView Rating Details
7/25/2017Deutsche BankDowngradeBuy -> Hold$65.00HighView Rating Details
6/20/2017Hilliard LyonsInitiated CoverageBuy$77.00LowView Rating Details
5/30/2017ArgusReiterated RatingBuy$60.00 -> $69.00LowView Rating Details
5/26/2017CL KingInitiated CoverageBuy -> Buy$71.00LowView Rating Details
5/24/2017Credit Suisse GroupBoost Price TargetOutperform$61.00 -> $67.00LowView Rating Details
2/16/2017GuggenheimBoost Price TargetBuy$60.00 -> $65.00N/AView Rating Details
2/16/2017Off Wall StreetReiterated RatingStrong Sell$35.00N/AView Rating Details
11/3/2016JPMorgan Chase & Co.Reiterated RatingHold$53.00N/AView Rating Details
9/29/2016Bank of AmericaInitiated CoverageBuy$60.00N/AView Rating Details
8/4/2016BarclaysBoost Price TargetEqual Weight$45.00 -> $49.00N/AView Rating Details
(Data available from 1/19/2016 forward)

Earnings

Zoetis (NYSE:ZTS) Earnings History and Estimates Chart

Earnings by Quarter for Zoetis (NYSE:ZTS)

Zoetis (NYSE ZTS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/15/2018$0.66N/AView Earnings Details
11/2/2017Q3 2017$0.63$0.65$1.32 billion$1.35 billionViewN/AView Earnings Details
8/8/2017Q2 2017$0.53$0.53$1.27 billion$1.27 billionViewListenView Earnings Details
5/4/2017Q1 2017$0.48$0.53$1.20 billion$1.23 billionViewListenView Earnings Details
2/16/2017Q416$0.45$0.47$1.28 billion$1.30 billionViewN/AView Earnings Details
11/2/2016Q316$0.46$0.52$1.22 billion$1.20 billionViewN/AView Earnings Details
8/3/2016Q216$0.44$0.49$1.17 billion$1.20 billionViewN/AView Earnings Details
5/4/2016Q116$0.41$0.48$1.10 billion$1.20 billionViewN/AView Earnings Details
2/16/2016Q415$0.39$0.43$1.25 billion$1.30 billionViewListenView Earnings Details
11/3/2015Q315$0.40$0.50$1.18 billion$1.20 billionViewN/AView Earnings Details
8/4/2015Q215$0.38$0.43$1.12 billion$1.20 billionViewN/AView Earnings Details
5/5/2015Q115$0.37$0.41$1.11 billion$1.10 billionViewN/AView Earnings Details
2/11/2015Q414$0.36$0.40$1.27 billion$1.30 billionViewN/AView Earnings Details
11/4/2014Q314$0.37$0.41$1.16 billion$1.20 billionViewN/AView Earnings Details
8/5/2014Q2 2014$0.39$0.38ViewN/AView Earnings Details
5/6/2014Q114$0.37$0.38$1.13 billion$1.10 billionViewN/AView Earnings Details
2/11/2014Q413$0.34$0.36$1.21 billion$1.25 billionViewN/AView Earnings Details
11/5/2013Q313$0.34$0.34$1.07 billion$1.10 billionViewN/AView Earnings Details
8/6/2013Q2 2013$0.36$0.36$1.13 billion$1.11 billionViewN/AView Earnings Details
4/30/2013Q1 2013$0.27$0.36$1.24 billion$1.09 billionViewN/AView Earnings Details
3/28/2013Q4 2012$0.34$0.07ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Zoetis (NYSE:ZTS) Earnings Estimates

2018 EPS Consensus Estimate: $2.99
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.69$0.69$0.69
Q2 20181$0.72$0.72$0.72
Q3 20181$0.79$0.79$0.79
Q4 20181$0.79$0.79$0.79
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Zoetis (NYSE:ZTS) Dividend Information

Next Dividend:3/1/2018
Annual Dividend:$0.42
Dividend Yield:0.55%
Dividend Growth:13.40% (3 Year Average)
Payout Ratio:22.11% (Trailing 12 Months of Earnings)
17.80% (Based on This Year's Estimates)
14.63% (Based on Next Year's Estimates)
Track Record:4 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Zoetis (NYSE:ZTS)

Zoetis (NYSE:ZTS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
12/12/2017quarterly$0.130.7%1/18/20181/19/20183/1/2018
10/5/2017quarterly$0.110.66%11/8/201711/9/201712/1/2017
5/12/2017quarterly$0.110.7%6/13/20176/15/20179/1/2017
2/15/2017quarterly$0.110.76%4/4/20174/6/20176/1/2017
12/6/2016quarterly$0.110.82%1/18/20171/20/20173/1/2017
10/7/2016quarterly$0.100.73%11/1/201611/3/201612/1/2016
5/13/2016quarterly$0.100.82%6/28/20166/30/20168/30/2016
2/22/2016quarterly$0.100.89%4/5/20164/7/20166/1/2016
12/17/2015quarterly$0.100.81%1/19/20161/21/20163/1/2016
10/2/2015quarterly$0.080.77%11/3/201511/5/201512/1/2015
7/22/2015quarterly$0.080.66%8/11/20158/13/20159/1/2015
3/2/2015quarterly$0.080.7%4/7/20154/9/20156/2/2015
12/18/2014quarterly$0.080.77%1/20/20151/22/20153/3/2015
10/2/2014quarterly$0.070.76%11/3/201411/5/201412/2/2014
7/31/2014quarterly$0.070.88%8/18/20148/20/20149/2/2014
3/26/2014quarterly$0.070.98%4/23/20144/27/20146/2/2014
12/19/2013quarterly$0.070.89%1/28/20141/30/20143/4/2014
9/12/2013quarterly$0.070.84%10/30/201311/1/201312/2/2013
6/20/2013quarterly$0.078/1/20139/2/2013
3/29/2013special$0.074/29/20135/1/20136/6/2013
3/28/2013quarterly$0.075/1/20136/6/2013
(Data available from 1/1/2013 forward)

Insider Trades

Zoetis (NYSE ZTS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.31%
Institutional Ownership Percentage: 93.14%
Insider Trades by Quarter for Zoetis (NYSE:ZTS)
Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Zoetis (NYSE ZTS) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/12/2017Catherine A KnuppInsiderSell5,785$60.16$348,025.6024,415View SEC Filing  
11/22/2016Kristin C PeckInsiderSell10,092$49.55$500,058.6022,768View SEC Filing  
11/8/2016Roxanne LaganoInsiderSell9,797$50.43$494,062.718,063View SEC Filing  
9/6/2016Michael B MccallisterDirectorBuy2,000$51.34$102,680.00View SEC Filing  
9/2/2016Andrew FentonInsiderSell13,870$51.25$710,837.5017,719View SEC Filing  
9/1/2016Heidi C ChenInsiderSell32,097$50.98$1,636,305.0646,060View SEC Filing  
5/9/2016Pershing Square Capital ManageDirectorSell16,850,000$46.55$784,367,500.00View SEC Filing  
8/8/2013Michael MccallisterDirectorBuy7,000$31.35$219,450.00View SEC Filing  
2/6/2013Frank A DamelioDirectorBuy5,000$26.00$130,000.00View SEC Filing  
2/6/2013Sandra J BeatyEVPBuy2,000$26.00$52,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Zoetis (NYSE ZTS) News Headlines

Source:
DateHeadline
Can These 4 Large-Cap Drug Stocks Deliver an Encore in 18?Can These 4 Large-Cap Drug Stocks Deliver an Encore in '18?
www.zacks.com - January 18 at 3:49 PM
Zoetis Inc. (ZTS) PT Raised to $84 at Stifel - StreetInsider.comZoetis Inc. (ZTS) PT Raised to $84 at Stifel - StreetInsider.com
www.streetinsider.com - January 18 at 11:44 AM
Jefferies Group Analysts Decrease Earnings Estimates for Zoetis Inc (ZTS)Jefferies Group Analysts Decrease Earnings Estimates for Zoetis Inc (ZTS)
www.americanbankingnews.com - January 18 at 6:08 AM
FY2018 EPS Estimates for Zoetis Inc Lifted by Analyst (ZTS)FY2018 EPS Estimates for Zoetis Inc Lifted by Analyst (ZTS)
www.americanbankingnews.com - January 17 at 5:02 PM
Zoetis Inc (ZTS) Expected to Post Quarterly Sales of $1.41 BillionZoetis Inc (ZTS) Expected to Post Quarterly Sales of $1.41 Billion
www.americanbankingnews.com - January 17 at 3:40 AM
Zoetis (ZTS) Receives "Buy" Rating from Jefferies GroupZoetis (ZTS) Receives "Buy" Rating from Jefferies Group
www.americanbankingnews.com - January 16 at 8:34 PM
 Brokerages Expect Zoetis Inc (ZTS) to Announce $0.66 Earnings Per Share Brokerages Expect Zoetis Inc (ZTS) to Announce $0.66 Earnings Per Share
www.americanbankingnews.com - January 15 at 9:14 PM
Zoetis Inc Expected to Post FY2020 Earnings of $3.66 Per Share (ZTS)Zoetis Inc Expected to Post FY2020 Earnings of $3.66 Per Share (ZTS)
www.americanbankingnews.com - January 15 at 4:16 PM
Zoetis (ZTS) Rating Lowered to Sell at Zacks Investment ResearchZoetis (ZTS) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - January 13 at 4:08 PM
Q1 2018 Earnings Forecast for Zoetis Inc Issued By William Blair (ZTS)Q1 2018 Earnings Forecast for Zoetis Inc Issued By William Blair (ZTS)
www.americanbankingnews.com - January 12 at 9:04 AM
Zoetis Inc (ZTS) to Post FY2018 Earnings of $3.00 Per Share, Gabelli ForecastsZoetis Inc (ZTS) to Post FY2018 Earnings of $3.00 Per Share, Gabelli Forecasts
www.americanbankingnews.com - January 10 at 1:18 PM
Investors In Zoetis Inc (NYSE:ZTS) Are Paying Above The Intrinsic ValueInvestors In Zoetis Inc (NYSE:ZTS) Are Paying Above The Intrinsic Value
finance.yahoo.com - January 9 at 4:22 PM
Zoetis (ZTS) Price Target Increased to $78.00 by Analysts at BMO Capital MarketsZoetis (ZTS) Price Target Increased to $78.00 by Analysts at BMO Capital Markets
www.americanbankingnews.com - January 9 at 10:36 AM
Zoetis (ZTS) Rating Reiterated by BMO Capital MarketsZoetis (ZTS) Rating Reiterated by BMO Capital Markets
www.americanbankingnews.com - January 8 at 12:38 PM
Zoetis (ZTS) Downgraded by Zacks Investment Research to HoldZoetis (ZTS) Downgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - January 6 at 5:46 PM
Noteworthy Tuesday Option Activity: X, EXPR, ZTS - Nasdaq.com - NasdaqNoteworthy Tuesday Option Activity: X, EXPR, ZTS - Nasdaq.com - Nasdaq
www.nasdaq.com - January 2 at 10:03 PM
UPDATE: Zoetis Inc. (ZTS) PT Raised to $85 at Craig-Hallum - StreetInsider.comUPDATE: Zoetis Inc. (ZTS) PT Raised to $85 at Craig-Hallum - StreetInsider.com
www.streetinsider.com - January 2 at 5:01 PM
 Brokerages Anticipate Zoetis Inc (ZTS) Will Post Earnings of $0.66 Per Share Brokerages Anticipate Zoetis Inc (ZTS) Will Post Earnings of $0.66 Per Share
www.americanbankingnews.com - December 30 at 1:24 AM
ZTS February 2018 Options Begin TradingZTS February 2018 Options Begin Trading
www.nasdaq.com - December 29 at 10:45 AM
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2017 Financial ResultsZoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - December 28 at 9:46 AM
Traders Buy High Volume of Zoetis Put Options (ZTS)Traders Buy High Volume of Zoetis Put Options (ZTS)
www.americanbankingnews.com - December 28 at 2:38 AM
Zoetis (ZTS) Given a $85.00 Price Target at Cantor FitzgeraldZoetis (ZTS) Given a $85.00 Price Target at Cantor Fitzgerald
www.americanbankingnews.com - December 27 at 7:16 AM
ETFs with exposure to Zoetis, Inc. : December 26, 2017ETFs with exposure to Zoetis, Inc. : December 26, 2017
finance.yahoo.com - December 26 at 8:04 PM
Zoetis Inc (ZTS) Given Consensus Rating of "Buy" by BrokeragesZoetis Inc (ZTS) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - December 26 at 4:39 PM
Zoetis Inc (ZTS) Given Average Rating of "Buy" by BrokeragesZoetis Inc (ZTS) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - December 26 at 4:39 PM
Zoetis Sees Unusually High Options Volume (ZTS)Zoetis Sees Unusually High Options Volume (ZTS)
www.americanbankingnews.com - December 24 at 3:10 AM
7 A-Rated Healthcare Stocks to Buy7 A-Rated Healthcare Stocks to Buy
finance.yahoo.com - December 23 at 4:32 AM
First Week of ZTS February 2018 Options TradingFirst Week of ZTS February 2018 Options Trading
www.nasdaq.com - December 19 at 4:18 PM
 Analysts Expect Zoetis Inc (ZTS) Will Post Quarterly Sales of $1.41 Billion Analysts Expect Zoetis Inc (ZTS) Will Post Quarterly Sales of $1.41 Billion
www.americanbankingnews.com - December 14 at 8:42 AM
ETFs with exposure to Zoetis, Inc. : December 13, 2017ETFs with exposure to Zoetis, Inc. : December 13, 2017
finance.yahoo.com - December 13 at 4:29 PM
Zacks: Analysts Expect Zoetis Inc (ZTS) Will Announce Earnings of $0.66 Per ShareZacks: Analysts Expect Zoetis Inc (ZTS) Will Announce Earnings of $0.66 Per Share
www.americanbankingnews.com - December 12 at 9:30 PM
Zoetis Inc (ZTS) Increases Dividend to $0.13 Per ShareZoetis Inc (ZTS) Increases Dividend to $0.13 Per Share
www.americanbankingnews.com - December 12 at 5:52 PM
A Ton of Love Delivered to Animals Taking Refuge from Californias Thomas WildfireA Ton of Love Delivered to Animals Taking Refuge from California's Thomas Wildfire
www.prnewswire.com - December 12 at 4:30 PM
Zoetis (ZTS) PT Set at $80.00 by Cantor FitzgeraldZoetis (ZTS) PT Set at $80.00 by Cantor Fitzgerald
www.americanbankingnews.com - December 12 at 12:46 PM
Zoetis raises dividend by 20%Zoetis raises dividend by 20%
finance.yahoo.com - December 12 at 11:03 AM
Zoetis Launches Vanguard® CIV H3N2/H3N8 Vaccine for Canine Influenza VirusZoetis Launches Vanguard® CIV H3N2/H3N8 Vaccine for Canine Influenza Virus
finance.yahoo.com - December 12 at 11:03 AM
Zoetis, Inc. :ZTS-US: Earnings Analysis: Q3, 2017 By the Numbers : December 12, 2017Zoetis, Inc. :ZTS-US: Earnings Analysis: Q3, 2017 By the Numbers : December 12, 2017
finance.yahoo.com - December 12 at 11:03 AM
Zoetis Declares First Quarter 2018 Dividend; Board Approves 20% Payment IncreaseZoetis Declares First Quarter 2018 Dividend; Board Approves 20% Payment Increase
finance.yahoo.com - December 11 at 4:29 PM
Zoetis Inc. (ZTS) Given Consensus Recommendation of "Buy" by AnalystsZoetis Inc. (ZTS) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - December 1 at 9:48 PM
Analyst: Zoetis Deserves To Trade At A Premium - BenzingaAnalyst: Zoetis Deserves To Trade At A Premium - Benzinga
www.benzinga.com - November 30 at 4:18 PM
Morgan Stanley Upgrades Zoetis (ZTS) to "Overweight"Morgan Stanley Upgrades Zoetis (ZTS) to "Overweight"
www.americanbankingnews.com - November 29 at 8:54 PM
Morgan Stanley Upgrades Zoetis Inc. (ZTS) to OverweightMorgan Stanley Upgrades Zoetis Inc. (ZTS) to Overweight
www.streetinsider.com - November 29 at 4:20 PM
Analyst: Zoetis Deserves To Trade At A PremiumAnalyst: Zoetis Deserves To Trade At A Premium
finance.yahoo.com - November 29 at 4:20 PM
Zoetis Inc. (ZTS) Expected to Post Quarterly Sales of $1.41 BillionZoetis Inc. (ZTS) Expected to Post Quarterly Sales of $1.41 Billion
www.americanbankingnews.com - November 27 at 11:44 PM
Zoetis Inc. (ZTS) Expected to Post Earnings of $0.66 Per ShareZoetis Inc. (ZTS) Expected to Post Earnings of $0.66 Per Share
www.americanbankingnews.com - November 25 at 1:20 AM
Zoetis Inc. (ZTS) Receives "Neutral" Rating from UBS AGZoetis Inc. (ZTS) Receives "Neutral" Rating from UBS AG
www.americanbankingnews.com - November 24 at 10:10 AM
IWR, ZTS, LRCX, ADI: ETF Inflow Alert - NasdaqIWR, ZTS, LRCX, ADI: ETF Inflow Alert - Nasdaq
www.nasdaq.com - November 21 at 2:37 AM
Zoetis Moves Up In Analyst Rankings, Passing PrologisZoetis Moves Up In Analyst Rankings, Passing Prologis
www.thestreet.com - November 20 at 12:33 PM
Zoetis Inc. (ZTS) PT Set at $80.00 by Cowen and CompanyZoetis Inc. (ZTS) PT Set at $80.00 by Cowen and Company
www.americanbankingnews.com - November 17 at 10:43 AM
Zoetis, Inc. : ZTS-US: Dividend Analysis : November 09th, 2017 (record date) : By the numbers : November 10, 2017Zoetis, Inc. : ZTS-US: Dividend Analysis : November 09th, 2017 (record date) : By the numbers : November 10, 2017
finance.yahoo.com - November 12 at 1:47 PM

SEC Filings

Zoetis (NYSE:ZTS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Zoetis (NYSE:ZTS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Zoetis (NYSE ZTS) Stock Chart for Friday, January, 19, 2018

Loading chart…

This page was last updated on 1/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.